Statistics

Total Visits

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study53

Select a period of time:

Number of views in the range

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study32

Views

Views
November 20240
December 20240
January 20250
February 20250
March 202518
April 202512
May 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
Hong Kong11
Germany1
Spain1
Finland1
United States1
 

Top cities views

Views
Hong Kong11
Council Bluffs1
Nuremberg1
Turku1